about
Glycosylation and epitope mapping of the 5T4 glycoprotein oncofoetal antigen5T4 interacts with TIP-2/GIPC, a PDZ protein, with implications for metastasisData donation after death: A proposal to prevent the waste of medical research dataTen Simple Rules for Protecting Research IntegrityReasons why nurses decline influenza vaccination: a qualitative studyShould academic journals publish e-cigarette research linked to tobacco companies?"Conferring authorship": biobank stakeholders' experiences with publication credit in collaborative research.Blinded by the light: Anonymization should be used in peer review to prevent bias, not protect refereesTotal synthesis, revised structure, and biological evaluation of biyouyanagin A and analogues thereof.Peer reviewers can meet journals' criteria for authorship.Cardio-pulmonary resuscitation of brain-dead organ donors: a literature review and suggestions for practice.Defining Nano, Nanotechnology and Nanomedicine: Why Should It Matter?Controlled Donation After Circulatory Determination of Death.The ethics of extracorporeal membrane oxygenation in brain-dead potential organ donors.Extracorporeal membrane oxygenation (ECMO) assisted cardiopulmonary resuscitation or uncontrolled donation after the circulatory determination of death following out-of-hospital refractory cardiac arrest-An ethical analysis of an unresolved clinicalPrioritising Healthcare Workers for Ebola Treatment: Treating Those at Greatest Risk to Confer Greatest Benefit.Targeting immune effector molecules to human tumor cells through genetic delivery of 5T4-specific scFv fusion proteins.Characterization of the murine 5T4 oncofoetal antigen: a target for immunotherapy in cancer.Ford and Edison in a modern regulatory environment: the first-in-human trial of night-work and artificial light.Transatlantic issues: report from Scotland.Art, (in)visibility, and Ebola: "What are the consequences of a digitally-created society in the psyche of the global community?".Data donation after death.Conflict or Confluence of Interest?Accessibility of prison healthcare for elderly inmates, a qualitative assessment.Intergenerational global heath.Assisted suicide for prisoners? Stakeholder and prisoner perspectives.The vulnerability of the individual benefit argument.A piece of my mind. Beyond conflicts of interest: disclosing medical biases.Conducting ethics research in prison: why, who, and what?Protecting prisoners' autonomy with advance directives: ethical dilemmas and policy issues.Homeopaths Without Borders practice exploitation not humanitarianism.Organ donation after assisted suicide: a potential solution to the organ scarcity problem.Rawls and religious paternalism.The ethics committee as ghost author.Heart donation after circulatory determination of death: ethically acceptable?Justice and the fetus: Rawls, children, and abortion.The Consequences of Vagueness in Consent to Organ Donation.Practical Considerations in Donation After Circulatory Determination of Death in Switzerland.Small groups, open doors: Fostering individual and group creativity within research communities.Effectiveness and Duration of Effect of Open-Label Lisdexamfetamine Dimesylate in Adults With ADHD.
P50
Q24534036-34AD58C4-5E45-4339-BC6C-E3517F872BA2Q28215877-3546DA9E-9543-4C60-AAB5-B20B4ACCC05BQ28602360-FBEF57A1-5E7F-451B-A27A-61A9AD0CCF77Q28974688-62480AC0-CAB4-4915-8111-76DE6BEACB31Q33617907-50EC6A3F-9370-40C7-B846-9DE37B763D75Q34495956-81D6982A-E02D-446D-B236-19F8FC3068F2Q35010382-56951D9B-204A-4710-9578-DE8FFD3A1A91Q36004233-ACBB6A2E-B5BE-40D9-9501-7BFA4CFC5CF6Q37039993-100449E4-5F4D-47FF-953D-615EB6E3456FQ38074640-DE429146-E2F8-41D1-B4FF-70324AFAFBDCQ38527613-D3E5E1A9-9577-4C60-8E3F-40F80F2B3918Q38587494-724FF1EA-8B15-42B6-9CB2-E22CDEE100BBQ38746374-CD78877A-4C9C-45B4-9CDA-0718EF113EE3Q38778627-D4C12584-B3AC-4C6A-99DA-654567BBCB06Q38906106-89DF15FE-731C-44FF-9679-DA9F49006EFCQ40170680-56F20EE4-2DF1-4BF2-8F83-35BB43E68FE3Q40696514-9F2DE588-FA81-4C74-A3D6-96ABD877EA68Q40732932-F9312DCA-99EA-4007-BD41-9E30753723E1Q42315560-CEC2CB3D-A560-4C96-8ECE-2D01D5B895C3Q43052462-256F5717-4FC1-4C83-840D-B07DDC85A1EDQ43917687-1084DE47-FA2B-457F-B155-42D59FA9A198Q45934832-E3637E5D-6D1E-4430-BB67-8C490799B5F7Q47765404-20C56293-D121-4CDC-BF90-906EB362A9C2Q47802538-6D9D1FB5-CDDA-4BAB-8B89-9AC016A20452Q48048293-93E2C766-32A9-419E-BDCB-F0D4019A345CQ48057716-36A571F4-741F-4744-8758-3E979A6D17D0Q48060822-B88AB6A3-3B1A-45D4-B5AF-DD79A937D894Q48067757-9C612B33-8CC4-4040-81A6-114C00F5D45EQ48071536-BFEF238F-529A-4EED-8B92-2AB2D94DA799Q48075822-F115C407-F4B6-4FD5-9101-C4D0AB7F3A99Q48166520-7F5E55F8-DCA1-4555-A838-97762A236229Q48295199-D815F376-5620-4CB5-824A-43943B1A6972Q48397841-26F9A79F-40EF-46B7-84F9-7FD9CB04FDE7Q48604220-3BBC9779-44CA-49B6-ADFE-363BA896F6E8Q48658231-B1315D0B-0FD3-44BF-AE4D-82FC7A9F00B8Q48711241-AAE60072-4C23-4CD4-8659-B7D7F1D58FF9Q48884512-9464AA6A-D1CB-4736-A39E-D82C6F00052DQ49544203-8211AB39-3959-4D17-B198-91A10F4D0542Q49913943-13C3EAA7-135C-4780-8B50-B220E9FA9CA4Q50710433-993E394B-87D3-40F9-8979-A18E3E4D06E7
P50
name
David M Shaw
@ast
David M Shaw
@en
David M Shaw
@es
David M Shaw
@nl
type
label
David M Shaw
@ast
David M Shaw
@en
David M Shaw
@es
David M Shaw
@nl
prefLabel
David M Shaw
@ast
David M Shaw
@en
David M Shaw
@es
David M Shaw
@nl